Venture capital deals

March 8, 2012, 8:01 PM UTC
Fortune

Bellicum Pharmaceuticals Inc., a Houston-based developer of cell therapies for treating serious and life threatening diseases, has raised $20 million in Series B funding from firms like AVG Ventures andRemeditex Ventureswww.bellicum.com

Switchfly (f.k.a. EzRez Software), a San Francisco-based SaaS provider of travel, loyalty and payment solutions, has raised $15 million in Series C funding. StarVest Partners led the round, and was joined by return backers Azure Capital Partners and Canaan Partners. www.switchfly.com

Exinda, a Boston-based provider of WAN optimization solutions, has raised $12 million in Series B funding. Greenspring Associates was joined by return backer OpenView Venture Partners.www.exinda.com

Triptrotting, a Pasadena, Calif.-based community for connecting travelers with locals, has raised $1 million in Series A funding. Backers include Google Ventures, WI Harper Group, Mark Suster, Dave McClure and Bill Gross. www.triptrotting.com

Want deal news in your inbox each morning? Then get Term Sheet!